David Mehalick - 16 Nov 2021 Form 4 Insider Report for Coeptis Therapeutics Inc. (COEP)

Role
CEO and President, Director, 10%+ Owner
Signature
/s/ David Mehalick
Issuer symbol
COEP
Transactions as of
16 Nov 2021
Net transactions value
$0
Form type
4
Filing time
18 Nov 2021, 13:00:12 UTC
Next filing
07 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COEP Common Stock Sale -1,200,000 -40% 1,800,000 16 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected by the reporting person in connection with a divorce settlement.